FibroHeal

Bengaluru, India Founded: 2017 • Age: 9 yrs Minicorn
Developer of silk proteins as biomaterials for wound healing

About FibroHeal

FibroHeal is a Healthcare company based in Bengaluru (India) founded in 2017 by Subramanian Shivaraman, Vivek Mishra, and Bharat Tandon. FibroHeal has raised $3.8 million across 9 funding rounds from investors including C-CAMP, Startup Karnataka and KITVEN. The company has 62 employees. FibroHeal was last valued at $7.05 million in November 2022. Its chief executive, as recorded, is Vivek Mishra. Its Indian entity Fibroheal Woundcare Private Limited reported revenue of β‚Ή5.37 Cr. FibroHeal offers products and services including D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and FibroZyme. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Dressing.

Company details

Developer of silk proteins as biomaterials for wound healing. The company is leveraging the biomaterial application of silk proteins to develop the most innovative advance and active wound care products to heal acute and chronic wounds. The company is working exclusively on healing different types of acute and chronic wounds and has a comprehensive product range addressing different stages of wounds.

  • Headquarters Bengaluru, India
  • Employees 62
  • Founders Subramanian Shivaraman, Vivek Mishra, Bharat Tandon
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website fibroheal.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Fibroheal Woundcare Private Limited
  • Date of Incorporation 06 Apr, 2017
  • Jurisdiction Doddaballapura, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹5.37 Cr

    FY 2026 · +3% YoY

  • Net Loss
    -₹4.97 Cr

    FY 2026 · -96% margin

  • EBITDA
    -₹3.41 Cr

    FY 2026 · -66% margin

  • Total Equity Funding
    $3.8M (USD)

    in 9 rounds

  • Latest Funding Round
    $1.47M (USD), Angel Round

    Jul 2026

  • Investors
    C-CAMP

    & 9 more

  • Employee Count
    62

Products & Services of FibroHeal

FibroHeal offers a comprehensive portfolio of products and services, including D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and FibroZyme.

D-Fibroheal Scarlite
Scar Management

Product for effective scar management in wound healing.

D-Fibroheal Ag Particle
Infection Control

Antimicrobial solution for controlling wound infections.

D-Fibroheal Particle
Wound Aid

Material for general wound care and healing support.

Fibrovid
Wound Care

Aid for viral or general skin wound treatment.

FibroZyme
Debridement

Enzyme-based product for tissue debridement in wounds.

Silk n Soft Moisturizing Cream
Moisture Balance

Cream to maintain moisture in wound care routines.

D-Fibroheal Foam Adhesive
Wound Dressing

Adhesive foam for protective wound coverage.

D-Fibroheal Ag Foam
Infection Control

Foam with antimicrobial properties for wounds.

D-Fibroheal Ag Foam Adhesive
Wound Dressing

Adhesive antimicrobial foam for wound protection.

FibroMoist Gel
Moisture Balance

Gel to provide hydration for wound healing.

Fibromoist Spray
Moisture Balance

Spray for applying moisture to wounds.

D-FIBROHEAL
Wound Aid

General product for aiding wound recovery.

D-FIBROHEAL MESHED
Wound Dressing

Meshed material for wound coverage and healing.

D-FIBROHEAL PU FOAM
Wound Dressing

Polyurethane foam for non-adhesive wound protection.

D-FIBROHEAL Ag
Infection Control

Antimicrobial version for infection prevention.

Funding Insights of FibroHeal

FibroHeal has successfully raised a total of $3.8M across 9 strategic funding rounds. The most recent funding activity was a Angel Round of $1.47 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.8M
  • Total Rounds 9
  • Last Round Angel Round β€” $1.47M
  • First Round $141,834

    (Dec 2018)

  • Investors Count 10

All 9 funding rounds of FibroHeal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2026$1.47MAngel Round––
–
Dec 2024$742,417Seed––
Nov 2022$552,479Seed$7.05MKITVEN
Mar 2022$1MDebt – Venture––
Apr 2021$597,335Seed$5.76MKarnataka Trustee
Mar 2020$99,233Seed$β€’β€’β€’β€’β€’C-CAMP
–
Nov 2019$195,017Angel Round$β€’β€’β€’β€’β€’Tejas Subramanian
Aug 2019Grant––
Dec 2018$141,834Angel Round$β€’β€’β€’β€’β€’Tejas Subramanian
Valuation history
DateValuationStage
Nov 2022$7.05Mβ€’β€’β€’β€’β€’β€’β€’β€’
Apr 2021$5.76Mβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2020$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of FibroHeal

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $7.05M (Nov 2022). 10 investors in total: 6 institutional and 4 angel.

Investors in FibroHeal

FibroHeal has secured backing from 10 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include C-CAMP, Startup Karnataka and KITVEN.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed by government financial institutions focused on early and growth stage startups
1999kitven.inBengaluru, India
Venture capital is provided to biotech and health-tech startups.
Bengaluru, India
Business incubation services are provided across multiple sectors.
birac.nic.inDelhi, India
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India.
2010ccamp.res.inBengaluru, India
Venture capital firm focused on multiple sectors
Bengaluru, India
Support for startups in Karnataka is delivered through policies, funding, and networking services.
2004missionstartupkarnataka.orgBengaluru, India

KK Narayanan

unknown_c693a7345a494cd1a

Tejas Subramanian

unknown_9ac375d27625493aa

Bharat Tandon

Angel investor and entrepreneur, focused on tech startups in India.
unknown_2de529d6fd0946c7b

Vivek Mishra

Angel investor and entrepreneur, focusing on tech startups in India.
unknown_2009af98df704c26a
Premium access

Investor details for FibroHeal

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Fibroheal Woundcare Private Limited (FibroHeal)

Fibroheal Woundcare Private Limited is the primary company behind FibroHeal. The board of Fibroheal Woundcare Private Limited currently have 2 directors; the longest-serving is Vivek Mishra, appointed in 2017. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Vivek Mishra
DIN 07616402
Director06 Apr 20179 yrs 7 moFibroheal Woundcare Private Limited
Bharat Tandon
DIN 00832149
Director06 Apr 20179 yrs 7 moFibroheal Woundcare Private Limited

People of FibroHeal

3 people are tracked at FibroHeal (3 in leadership); the tracked headcount is 62.

NameRoleGroup
Co-Founder & DirectorLeadership
Co-Founder & CEOLeadership
Co-Founder & DirectorLeadership
Premium access

Complete people profiles for FibroHeal

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of FibroHeal

Figures of Fibroheal Woundcare Private Limited, the primary company behind FibroHeal, for FY 2026. Revenue was ₹5.37 Cr (+3% year on year). Net loss was -₹4.97 Cr (-96% margin). EBITDA was -₹3.41 Cr (-66% margin). Revenue has grown at a compounded annual rate of +33% over three years and +79% over five years.

  • ₹5.37 CrRevenue · FY 2026 · +3% YoY
  • -₹4.97 CrNet loss · -96% margin
  • -₹3.41 CrEBITDA · -66% margin
  • ₹1.70 CrPaid-up capital
  • 29Employees (provident fund records)
  • +33%Revenue CAGR, 3 years
  • +79%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Fibroheal Woundcare Private Limited are on its company page.

Premium access

Detailed financial statements for FibroHeal

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of FibroHeal

4 dated milestones of FibroHeal across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded FibroHeal is founded.
  2. Funding First funding round of $142K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Angel Round, of $1.5M.

Web traffic of FibroHeal

The website of FibroHeal (fibroheal.com) receives about 3.6K visits a month.

  • Monthly visits
    3.6K

    ▼ 45.9% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fibroheal

Premium access

Complete news archive for FibroHeal

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FibroHeal

FibroHeal was founded in 2017 and raised its 1st funding round 1 year after it was founded.

FibroHeal is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Vivek Mishra is the CEO of FibroHeal, as recorded in our data. They have also founded this company.

FibroHeal is a funded company, having raised a total of $3.8M across 9 funding rounds to date. The company's 1st funding round was a Angel Round of $141.83K, raised on Dec 2018.

FibroHeal has 62 employees.

The primary company behind FibroHeal, Fibroheal Woundcare Private Limited, reported revenue of β‚Ή5.37 Cr for FY 2026, up 3% year on year.

Developer of silk proteins as biomaterials for wound healing. The company is leveraging the biomaterial application of silk proteins to develop the most innovative advance and active wound care products to heal acute and chronic wounds. The company is working exclusively on healing different types of acute and chronic wounds and has a comprehensive product range addressing different stages of wounds.

FibroHeal offers D-Fibroheal Scarlite, D-Fibroheal Ag Particle, D-Fibroheal Particle, Fibrovid, and 6 more products and services.

FibroHeal has 10 investors. Key investors include C-CAMP, Startup Karnataka, KITVEN, KK Narayanan, and Karnataka Trustee.

The valuation of FibroHeal is $7.05M as of Nov 2022.

FibroHeal operates through Fibroheal Woundcare Private Limited.

The legal entities of FibroHeal currently have 2 directors, including Vivek Mishra, Bharat Tandon.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available